Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion (Q39069309)

8 September 2017

Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion (English)

1 reference

8 September 2017

1 reference

Chih-Chien Yao

1

1 reference

8 September 2017

Chuan-Mo Lee

2

1 reference

8 September 2017

Chao-Hung Hung

3

1 reference

8 September 2017

Jing-Houng Wang

4

1 reference

8 September 2017

Tsung-Hui Hu

5

1 reference

8 September 2017

Sheng-Nan Lu

6

1 reference

8 September 2017

Chi-Sin Changchien

7

1 reference

8 September 2017

Mei-Chin Hsu

8

1 reference

8 September 2017

Chien-Hung Chen

9

1 reference

8 September 2017

language of work or name

1 reference

1 May 2015

1 reference

Journal of Gastroenterology and Hepatology

8 September 2017

1 reference

8 September 2017

30

1 reference

8 September 2017

918-924

1 reference

8 September 2017

5

1 reference

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

8 September 2017

1 reference

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

21 January 2018

1 reference

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

21 January 2018

1 reference

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

21 January 2018

1 reference

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion

21 January 2018

1 reference

Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion

21 January 2018

1 reference

Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation

21 January 2018

1 reference

Determinants for sustained HBeAg response to lamivudine therapy

21 January 2018

1 reference

Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study

21 January 2018

1 reference

21 January 2018

1 reference

The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.

21 January 2018

1 reference

Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion

21 January 2018

1 reference

Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients

21 January 2018

1 reference

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir

21 January 2018

1 reference

The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment

21 January 2018

1 reference

Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan

21 January 2018

1 reference

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

21 January 2018

1 reference

Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan

21 January 2018

1 reference

Time-dependent ROC curves for censored survival data and a diagnostic marker

21 January 2018

1 reference

Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B.

21 January 2018

1 reference

Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.

21 January 2018

1 reference

Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion

21 January 2018

1 reference

On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients

21 January 2018

1 reference

Relapse rate and associated-factor of recurrence after stopping NUCs therapy with different prolonged consolidation therapy in HBeAg positive CHB patients

21 January 2018

1 reference

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients

21 January 2018

1 reference

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation

21 January 2018

1 reference

Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12874

1 reference

8 September 2017

1 reference